company background image
JNJ logo

Johnson & Johnson NYSE:JNJ Stock Report

Last Price

US$144.47

Market Cap

US$347.8b

7D

0.4%

1Y

-7.1%

Updated

23 Dec, 2024

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$174.28
FV
17.1% undervalued intrinsic discount
3.33%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
4 days ago author updated this narrative

Johnson & Johnson Competitors

Price History & Performance

Summary of share price highs, lows and changes for Johnson & Johnson
Historical stock prices
Current Share PriceUS$144.47
52 Week HighUS$168.85
52 Week LowUS$142.75
Beta0.49
1 Month Change-6.90%
3 Month Change-11.25%
1 Year Change-7.07%
3 Year Change-14.85%
5 Year Change-0.57%
Change since IPO23,015.24%

Recent News & Updates

Johnson & Johnson: Dividend Legend At A Discount

Dec 19

Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View

Dec 06

Recent updates

Johnson & Johnson: Dividend Legend At A Discount

Dec 19

Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View

Dec 06

How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding

Nov 28

Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive

Nov 19

Johnson & Johnson: Tracking Well Above The Industry

Nov 13

Johnson & Johnson: Q3 Earnings Highlights Resilience And New Growth

Oct 19

Johnson & Johnson Q3 Earnings Preview: Dividend Dependability And Steady Growth

Oct 11

Johnson & Johnson: A Sell-Rated Dividend King

Sep 23

Shareholder Returns

JNJUS PharmaceuticalsUS Market
7D0.4%-0.3%-2.7%
1Y-7.1%7.9%23.4%

Return vs Industry: JNJ underperformed the US Pharmaceuticals industry which returned 7.9% over the past year.

Return vs Market: JNJ underperformed the US Market which returned 23.4% over the past year.

Price Volatility

Is JNJ's price volatile compared to industry and market?
JNJ volatility
JNJ Average Weekly Movement1.9%
Pharmaceuticals Industry Average Movement10.6%
Market Average Movement6.3%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: JNJ has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: JNJ's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1886131,900Joaquin Duatowww.jnj.com

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke.

Johnson & Johnson Fundamentals Summary

How do Johnson & Johnson's earnings and revenue compare to its market cap?
JNJ fundamental statistics
Market capUS$347.83b
Earnings (TTM)US$14.77b
Revenue (TTM)US$87.70b

23.6x

P/E Ratio

4.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JNJ income statement (TTM)
RevenueUS$87.70b
Cost of RevenueUS$26.84b
Gross ProfitUS$60.85b
Other ExpensesUS$46.09b
EarningsUS$14.77b

Last Reported Earnings

Sep 29, 2024

Next Earnings Date

Jan 22, 2025

Earnings per share (EPS)6.13
Gross Margin69.39%
Net Profit Margin16.84%
Debt/Equity Ratio51.0%

How did JNJ perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

79%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 03:48
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/29
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Johnson & Johnson is covered by 61 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Charles ButlerBarclays